Establish and implement IIT and CTA strategies in China tailored to indication and modality, to support early clinical development across multiple genetic medicine programs.
Lead global clinical development for programs with first-in-human clinical trials initiated in China, including FIH and early PoC study design and execution; co-lead China site development for global trials involving Chinese sites.
Act as a core member of global program teams, representing China clinical development and ensuring strong alignment with global development strategy, governance, and decision-making processes.
Build and partner with cross-functional teams across Clinical, Regulatory, Safety, Biometrics, and CMC in both China and the . to drive high-quality, compliant, and efficient clinical trial execution.
Support due diligence and asset evaluation for China-originated assets and global programs with major China involvement within t...
Ready to Apply?
Join thousands of Americans building their careers